Cargando…

A New Form of Specific Targeting Cancer Immunotherapy Using Anti‐tumor Monoclonal Antibody‐conjugated Lymphokine‐activated Killer Cells

Cross‐linking of effector T cells to target cancer cells augments their tumor lytic activities. Here we describe a new method of conjugating lymphokine‐activated killer (LAK) cells with cancer‐specific monoclonal antibody. The LAK cells were biotinylated, treated with avidin, and conjugated with bio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiraiwa, Hiroshi, Sekine, Teruaki, Tobisu, Ken‐ichi, Kakizoe, Tadao, Koiso, Kenkichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 1991
Materias:	Rapid Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5918496/ https://www.ncbi.nlm.nih.gov/pubmed/1906847 http://dx.doi.org/10.1111/j.1349-7006.1991.tb01895.x

Ejemplares similares

IMMUNOTHERAPY OF SOLID TOMOR BY INTRATUMORAL INFUSION OF LYMPHOKINE‐ACTIVATED KILLER CELLS
por: Yamaki, Toshiaki, et al.
Publicado: (1988)

COAMPLIFICATION OF THE hst‐1 AND int‐2 GENES IN HUMAM CANCERS
por: Tsutsumi, Masakazu, et al.
Publicado: (1988)

Vertical Transmission of HTLV‐1 in HTLV‐1 Carrier Rat
por: Ami, Yoshihiro, et al.
Publicado: (1992)

Trial to Induce Prostatic Cancer in ACI/Seg Rats Treated with a Combination of 3,2′‐Dimethyl‐4‐aminobiphenyl and Ethinyl Estradiol
por: Takai, Kazuhiro, et al.
Publicado: (1991)

Validity of Short‐term Examination for Antipromoters of Bladder Carcinogenesis
por: Kakizoe, Tadao, et al.
Publicado: (1988)

Lymphokine‐activated Killer Induction and Its Regulation by Macrophages in Malignant Pleural Effusions
por: Yanagawa, Hiroaki, et al.
Publicado: (1989)

Monoclonal antibody to a triggering structure expressed on rat natural killer cells and adherent lymphokine-activated killer cells
Publicado: (1989)

Natural killer and lymphokine activated killer cell functions in Hodgkin's disease.
por: Rajaram, N., et al.
Publicado: (1990)

Lymphokine-activated killer cells. Analysis of progenitors and effectors
Publicado: (1986)

Characterization of Transendothelial Migratory Lymphokine‐activated Killer Cells
por: Nakano, Koji, et al.
Publicado: (1996)

Lymphokine-activated killer cell phenomenon. III. Evidence that IL-2 is sufficient for direct activation of peripheral blood lymphocytes into lymphokine-activated killer cells
Publicado: (1983)

Establishment of Mouse Lymphokine‐activated Killer Cell Clones and Their Properties
por: Kato, Kazunori, et al.
Publicado: (1991)

Enhanced lymphokine-activated killer cell activity by an immunomodulator, Roquinimex.
por: Vaz, F., et al.
Publicado: (1995)

Induction of lymphokine-activated killer-like cells by cancer chemotherapy
Publicado: (1988)

The Heterogeneity of Target Recognition by Lymphokine‐activated Killer Precursor Cells
por: Ibayashi, Yukihiro, et al.
Publicado: (1990)

Lymphokine-activated killer cells in rats. III. A simple method for the purification of large granular lymphocytes and their rapid expansion and conversion into lymphokine-activated killer cells
Publicado: (1988)

Enhanced Tumor Localization of Monoclonal Antibody by Treatment with Kininase II Inhibitor and Angiotensin II
por: Noguchi, Akinori, et al.
Publicado: (1992)

Lymphokines
por: Hamblin, Anne S
Publicado: (1998)

Lymphokine-activated killer cell transplantation after anti-cancer treatment in two aged cats
por: Maeta, Noritaka, et al.
Publicado: (2019)

Augmentation by Tumor Necrosis Factor α of the Systemic Therapeutic Effect of Lymphokine‐activated Killer Cells in Adoptive Immunotherapy of Murine Tumor
por: Kato, Kazunori, et al.
Publicado: (1991)

Accumulation of adoptively transferred adherent, lymphokine-activated killer cells in murine metastases
Publicado: (1991)

Interleukin 5 enhances interleukin 2-mediated lymphokine-activated killer activity
Publicado: (1989)

Immune activation by combination human lymphokine-activated killer and dendritic cell therapy
por: West, E J, et al.
Publicado: (2011)

Enhancing Effect of Pokeweed Mitogen on the Proliferation and the Cytotoxicity of Lymphokine‐activated Killer Cells
por: Kimoto, Yasuhiko, et al.
Publicado: (1992)

Use of a Local Immunotherapy as an Adjunctive Tool for the Generation of Human Monoclonal Antibodies from Regional Lymph Nodes of Colonic Cancer Patients
por: Yagyu, Toshio, et al.
Publicado: (1992)

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis
Publicado: (1986)

Human lymphokine-activated killer cells are cytotoxic against cells infected with Toxoplasma gondii
Publicado: (1992)

Influence of transfusion of lymphokine-activated T killer cells on inflammatory responses in dogs after laparotomy
por: MIE, Keiichiro, et al.
Publicado: (2016)

Generation and Characterization of Lymphokine‐activated Killer Cells against Fresh Human Leukemia Cells
por: Tahara, Tohru, et al.
Publicado: (1988)

Two Populations of Mouse Lymphokine‐activated Killer Cells Separated by Use of Soybean Agglutinin
por: Takano, Mariko, et al.
Publicado: (1989)

Reinforced Cytotoxicity of Lymphokine‐activated Killer Cells toward Glioma Cells by Transfection of the Killer Cells with the γ‐Interferon Gene
por: Mizuno, Masaaki, et al.
Publicado: (1995)

Analysis by Step Sectioning of Early Invasive Bladder Cancer with Special Reference to G3·pT1 Disease
por: Kakizoe, Tadao, et al.
Publicado: (1992)

In vitro Anti‐tumor Activity of Anti‐c‐erbB‐2 × Anti‐CD3ɛ Bifunctional Monoclonal Antibody
por: Sugiyama, Yoshihiro, et al.
Publicado: (1992)

Heterogeneity of helper/inducer T lymphocytes. I. Lymphokine production and lymphokine responsiveness
Publicado: (1987)

Oligonucleotide Sequences Required for Natural Killer Cell Activation
por: Kuramoto, Etsuro, et al.
Publicado: (1992)

T Cell Receptor‐independent Cell‐mediated Cytotoxicity by Nude Mouse Lymphokine‐activated Killer Cells
por: Nishimura, Takashi, et al.
Publicado: (1991)

Lymphokine-activated killer cell susceptibility and adhesion molecule expression of multidrug resistant breast carcinoma
por: Savas, Burhan, et al.
Publicado: (2006)

Lysis of allogeneic and autologous melanoma cells by IL-7-induced lymphokine-activated killer cells.
por: Böhm, M., et al.
Publicado: (1994)

Oxidized-Desialylated Low-Density Lipoprotein Inhibits the Antitumor Functions of Lymphokine Activated Killer Cells
por: Aguilar Díaz de león, Jesús S, et al.
Publicado: (2021)

Mechanisms of selective killing of neuroblastoma cells by natural killer cells and lymphokine activated killer cells. Potential for residual disease eradication.
por: Foreman, N. K., et al.
Publicado: (1993)

Cannot write session to /tmp/vufind_sessions/sess_0sfc7emv4sd39o4p1d8cfhcf8i